This triple mechanism of action distinguishes it from existing agents such as semaglutide (GLP-1 only) or tirzepatide (GLP-1/GIP)
On raw weight-loss numbers, retatrutide reached a numerically larger mean reduction (about 24% at 48 weeks in phase 2) than tirzepatide (about 22.5% at 72 weeks in phase 3), and its sponsor-reported phase 3 topline figures are higher still
If you're evaluating GLPatch because you want to avoid injections, the conversation now has more options in it than it used to
The formulation acts at multiple regulatory nodes along the gut-pancreas-peripheral tissue axis, simultaneously boosting hormone secretion and improving cellular glucose utilization
High demand has led to counterfeit Ozempic entering the U.S
Current FDA-approved treatments for alcohol use disorder include disulfiram, acamprosate, and naltrexone